CYPH

Cypherpunk Technologies Inc. - Common Stock (CYPH)

About Cypherpunk Technologies Inc. - Common Stock (CYPH)

Cypherpunk Technologies, Inc. is a clinical-stage biopharmaceutical company focused on developing targeted and immuno-oncology therapeutics. Its novel therapies are designed to treat patients with cancer. The company was founded on January 3, 2011 and is headquartered in Cambridge, MA.

Details

Daily high

$2.49

Daily low

$2.13

Price at open

$2.22

52 Week High

$3.70

52 Week Low

$0.27

Market cap

260.8M

Dividend yield

Volume

17.1M

Avg. volume

9.3M

P/E ratio

4.28

Cypherpunk Technologies Inc. - Common Stock News